204 related articles for article (PubMed ID: 21948176)
1. Essential roles for Pot1b in HSC self-renewal and survival.
Wang Y; Shen MF; Chang S
Blood; 2011 Dec; 118(23):6068-77. PubMed ID: 21948176
[TBL] [Abstract][Full Text] [Related]
2. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.
He H; Wang Y; Guo X; Ramchandani S; Ma J; Shen MF; Garcia DA; Deng Y; Multani AS; You MJ; Chang S
Mol Cell Biol; 2009 Jan; 29(1):229-40. PubMed ID: 18936156
[TBL] [Abstract][Full Text] [Related]
3. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
Beier F; Foronda M; Martinez P; Blasco MA
Blood; 2012 Oct; 120(15):2990-3000. PubMed ID: 22932806
[TBL] [Abstract][Full Text] [Related]
4. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
[TBL] [Abstract][Full Text] [Related]
5. Telomere protection by TPP1 is mediated by POT1a and POT1b.
Kibe T; Osawa GA; Keegan CE; de Lange T
Mol Cell Biol; 2010 Feb; 30(4):1059-66. PubMed ID: 19995905
[TBL] [Abstract][Full Text] [Related]
6. Paracrine Interaction of Cancer Stem Cell Populations Is Regulated by the Senescence-Associated Secretory Phenotype (SASP).
Lagunas AM; Francis M; Maniar NB; Nikolova G; Wu J; Crowe DL
Mol Cancer Res; 2019 Jul; 17(7):1480-1492. PubMed ID: 31043491
[TBL] [Abstract][Full Text] [Related]
7. Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation.
Li X; Wilson AF; Du W; Pang Q
Stem Cell Reports; 2018 Feb; 10(2):339-346. PubMed ID: 29307578
[TBL] [Abstract][Full Text] [Related]
8. The shelterin complex and hematopoiesis.
Jones M; Bisht K; Savage SA; Nandakumar J; Keegan CE; Maillard I
J Clin Invest; 2016 May; 126(5):1621-9. PubMed ID: 27135879
[TBL] [Abstract][Full Text] [Related]
9. Engineered telomere degradation models dyskeratosis congenita.
Hockemeyer D; Palm W; Wang RC; Couto SS; de Lange T
Genes Dev; 2008 Jul; 22(13):1773-85. PubMed ID: 18550783
[TBL] [Abstract][Full Text] [Related]
10. Dysfunctional telomeres and hematological disorders.
Fiorini E; Santoni A; Colla S
Differentiation; 2018; 100():1-11. PubMed ID: 29331736
[TBL] [Abstract][Full Text] [Related]
11. Pot1b -/- tumors activate G-quadruplex-induced DNA damage to promote telomere hyper-elongation.
Takasugi T; Gu P; Liang F; Staco I; Chang S
Nucleic Acids Res; 2023 Sep; 51(17):9227-9247. PubMed ID: 37560909
[TBL] [Abstract][Full Text] [Related]
12. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination.
He H; Multani AS; Cosme-Blanco W; Tahara H; Ma J; Pathak S; Deng Y; Chang S
EMBO J; 2006 Nov; 25(21):5180-90. PubMed ID: 17053789
[TBL] [Abstract][Full Text] [Related]
13. Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in mice.
Farrés J; Martín-Caballero J; Martínez C; Lozano JJ; Llacuna L; Ampurdanés C; Ruiz-Herguido C; Dantzer F; Schreiber V; Villunger A; Bigas A; Yélamos J
Blood; 2013 Jul; 122(1):44-54. PubMed ID: 23678004
[TBL] [Abstract][Full Text] [Related]
14. Telomere length in inherited bone marrow failure syndromes.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
[TBL] [Abstract][Full Text] [Related]
15. p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.
Wang Y; Sharpless N; Chang S
J Clin Invest; 2013 Oct; 123(10):4489-501. PubMed ID: 24091330
[TBL] [Abstract][Full Text] [Related]
16. Dysfunctional telomeres induce p53-dependent and independent apoptosis to compromise cellular proliferation and inhibit tumor formation.
Wang Y; Wang X; Flores ER; Yu J; Chang S
Aging Cell; 2016 Aug; 15(4):646-60. PubMed ID: 27113195
[TBL] [Abstract][Full Text] [Related]
17. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
Gramatges MM; Bertuch AA
Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
[TBL] [Abstract][Full Text] [Related]
18. Protection of telomeres 1 proteins POT1a and POT1b can repress ATR signaling by RPA exclusion, but binding to CST limits ATR repression by POT1b.
Kratz K; de Lange T
J Biol Chem; 2018 Sep; 293(37):14384-14392. PubMed ID: 30082315
[TBL] [Abstract][Full Text] [Related]
19. Telomere dysfunction in human bone marrow failure syndromes.
Shtessel L; Ahmed S
Nucleus; 2011; 2(1):24-9. PubMed ID: 21647296
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
Agarwal S
Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
